Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381262 · ClinicalTrials.gov registry record · NA
Fitbit / Healthy Weight Management Study
A NA study, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 213
- Enrollment target
NCT02381262: Completed NA study, sponsored by Lancaster General Hospital.
NCT02381262 is a NA study that has completed, run by Lancaster General Hospital. The registered enrollment target is 213 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02381262, a NA study, has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
Study Summary
Study Aims Specifically with our Healthy Weight Management patients that are pursuing sleeve gastrectomy surgery, the investigators would like to determine if the Fitbit is associated with health outcomes in this population. Primary Outcome • Percentage of excess weight loss - Does the use of a Fitbit positively affect the percentage of excess body weight loss in vertical sleeve gastrectomy patients? Secondary Outcomes * Lifestyle changes and Exercise patterns - Does the use of a Fitbit foster positive lifestyle and exercise pattern changes in post-operative VSG patients? * Resolution of comorbidity - Does the use of a Fitbit positively affect patient health via reduction of co-morbid conditions associated with morbid obesity following VSG surgery?
Primary Outcome
Does the use of a Fitbit positively affect the percentage of excess body weight loss in VSG patients? Subjects enrolled in the study will have ideal body weight (IBW) calculated upon entry into the bariatric program and entered into the electronic health record. IBW calculations are based on the Met Life IBW charts. EWL at the end of one year will be calculated as follows: EWL% = (ABW - CW)/EBW \*100 EWL%: Percentage of excess weight loss CW: Current weight (to be collected at regular interval
Interventions
- BEHAVIORAL Fitbit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
What the finished NCT02381262 record still lists
NCT02381262 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Fitbit is the first listed.
NCT02381262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02381262 about?
NCT02381262 is a clinical study titled "Fitbit / Healthy Weight Management Study". Study Aims Specifically with our Healthy Weight Management patients that are pursuing sleeve gastrectomy surgery, the investigators would like to determine if the Fitbit is associated with health outcomes in this population. Primary Outcome • Percentage of excess weight loss - Does the use of a Fi...
What is the current status of trial NCT02381262?
This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2015-10. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT02381262?
The interventions under investigation include: Fitbit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02381262?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02381262's enrollment target sits among peer trials
213 488th of 2000 higher than 1,512 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia